Ocular Therapeutix™ Announces FDA Approval of DEXTENZA® for the Treatment of Post-Operative Pain Following Ocular Surgery

Monday, December 3, 2018 8:30 a.m. ET  

Webcast Presentation

Title
Ocular Therapeutix™ Announces FDA Approval of DEXTENZA® for the Treatment of Post-Operative Pain Following Ocular Surgery
Date / Time
12/03/18 8:30 a.m. ET